Dr. Jia Wang 王嘉
Chief Physician, Associate Professor
Department of Thoracic Surgery II, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for lung cancer, pulmonary nodules, esophageal cancer, mediastinal tumors, and other chest tumors. Specializes in single-port thoracoscopy. Focuses on comprehensive treatment combining surgery with targeted and immunotherapy.
Dr. Wang holds a medical doctorate and serves as Chief Physician and Associate Professor at Peking University. A visiting scholar at Harvard Medical School from 2012 to 2013, Dr. Wang is Deputy Director of the Surgical Teaching and Research Office at Peking University Cancer Hospital. The doctor has published over ten papers as first author and leads multiple research projects on chest tumors.
Professional roles
- Vice Chair, Thoracic Surgery Youth Committee, Beijing Medical Association
- Member, Tumor Surgery Professional Committee, Beijing Physician Standardized Training Committee
- Member, Esophageal Cancer Professional Committee, Beijing
- Member, Tumor Nutrition Professional Committee, Chinese Medical Association
Name order: in Chinese the family name comes first (Wang Jia). Papers usually list the name as Jia Wang or Wang J.
Selected publications
43 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Transl Med, 2020 (first author): Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation. PubMed 32175416
- Ann Transl Med, 2020 (first author): External validation of the eighth edition of the TNM classification for lung cancer in 3,611 surgically treated patients at a single institution. PubMed 32175415
- J Cancer Res Clin Oncol, 2019 (first author): Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients. PubMed 30474757
- World J Gastroenterol, 2014 (first author): Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma. PubMed 25561808
- J Cancer Res Clin Oncol, 2014 (first author): Evaluation of the 7th edition of the TNM classification for lung cancer at a single institution. PubMed 24676426
- Beijing Da Xue Xue Bao Yi Xue Ban, 2009 (first author): [Application of the 2007 lung cancer staging system by International Association for the Study of Lung Cancer]. PubMed 19727235
- Zhonghua Wei Chang Wai Ke Za Zhi, 2006 (senior author): [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer]. PubMed 16721678
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion